
Rand Capital Corporation EBITDA 2011-2026 | RAND
Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.[1]
EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.
EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.
However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.
Annual EBITDA Rand Capital Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 37.7 K | - | - | - | -2.34 M | 1.04 M | 113 K | 131 K | 873 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.04 M | -2.34 M | -23.5 K |
References
- Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.
EBITDA of other stocks in the Diversified financials industry
| Issuer | EBITDA | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Silvercrest Asset Management Group
SAMG
|
1.54 M | $ 14.14 | -0.56 % | $ 134 M | ||
|
Altisource Asset Management Corporation
AAMC
|
247 K | - | -1.53 % | $ 3.77 M | ||
|
Ashford
AINC
|
36.2 M | - | 0.2 % | $ 15.3 M | ||
|
Ares Capital Corporation
ARCC
|
1.21 B | $ 17.94 | 0.45 % | $ 7.59 B | ||
|
Atlas Corp.
ATCO
|
1.13 B | - | -0.1 % | $ 4.45 B | ||
|
Ameriprise Financial
AMP
|
151 M | $ 439.02 | -0.69 % | $ 42.5 B | ||
|
Арсагера
ARSA
|
-7.94 M | - | - | - | ||
|
Jupai Holdings Limited
JP
|
5.3 M | - | 0.98 % | $ 12.7 M | - | |
|
AssetMark Financial Holdings
AMK
|
35.5 M | - | - | $ 2.61 B | ||
|
TCG BDC, Inc.
CGBD
|
158 M | $ 10.7 | -0.47 % | $ 589 M | ||
|
BlackRock
BLK
|
6.7 B | $ 943.26 | 2.05 % | $ 141 B | ||
|
Bain Capital Specialty Finance, Inc.
BCSF
|
22.4 K | $ 11.98 | 0.59 % | $ 773 M | ||
|
Blucora
BCOR
|
26.4 M | - | -0.29 % | $ 1.31 B | ||
|
МЕРИДИАН
MERF
|
-47.2 M | - | - | - | ||
|
Русс-Инвест
RUSI
|
12.4 M | - | - | - | ||
|
Сафмар
SFIN
|
10.6 B | - | - | - | ||
|
The Bank of New York Mellon Corporation
BK
|
1.85 B | $ 115.38 | -0.68 % | $ 81.9 B | ||
|
Ares Management Corporation
ARES
|
32.2 M | $ 100.51 | -1.24 % | $ 31.5 B | ||
|
Cohen & Steers
CNS
|
182 M | $ 63.28 | 1.23 % | $ 3.19 B | ||
|
Fidus Investment Corporation
FDUS
|
66.1 M | $ 17.79 | 0.68 % | $ 435 M | ||
|
The Carlyle Group
CG
|
192 M | $ 46.38 | 1.62 % | $ 16.7 B | ||
|
Diamond Hill Investment Group
DHIL
|
45.1 M | $ 173.12 | 0.3 % | $ 477 M | ||
|
Great Elm Capital Corporation
GECC
|
36.5 | $ 4.93 | -3.71 % | $ 110 M | ||
|
Gladstone Capital Corporation
GLAD
|
15.2 M | $ 17.8 | 1.66 % | $ 553 M | ||
|
Apollo Investment Corporation
AINV
|
-373 M | - | 0.52 % | $ 730 M | ||
|
CI Financial Corp
CIXX
|
937 M | - | -0.7 % | $ 2.9 B | - | |
|
Tekla Healthcare Investors
HQH
|
-288 M | $ 18.16 | 1.34 % | $ 778 M | ||
|
Tekla Life Sciences Investors
HQL
|
-138 M | $ 16.57 | 1.22 % | $ 384 M | ||
|
Eaton Vance Corp.
EV
|
378 M | - | -0.98 % | $ 8.58 B | ||
|
Horizon Technology Finance Corporation
HRZN
|
22 M | $ 4.04 | - | $ 70.8 M | ||
|
Federated Hermes
FHI
|
522 M | $ 56.6 | -0.68 % | $ 4.25 B | ||
|
Harvest Capital Credit Corporation
HCAP
|
-1.21 M | - | - | $ 57.7 M | ||
|
Medley Management Inc.
MDLY
|
-3.99 M | - | - | $ 18.3 M | ||
|
Investcorp Credit Management BDC, Inc.
ICMB
|
45.4 M | $ 1.96 | -1.2 % | $ 26.9 M | ||
|
Puhui Wealth Investment Management Co., Ltd.
PHCF
|
-3.65 M | - | - | $ 5.54 M | ||
|
Puyi
PUYI
|
-68.5 M | - | 33.93 % | $ 811 M | ||
|
Waddell & Reed Financial, Inc.
WDR
|
107 M | - | -0.04 % | $ 1.55 B |